In colorectal cancer, FTY720 was found to promote PP2A-mediated degradation of Polycomb Group RING Finger Protein 4, BMI1, thereby preventing Polycomb Repressive Complex 1 (PRC1)-based epigenetic modifications (156). This evidence concerns the gene BMI1 and colorectal cancer.